# A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy

> **NCT00238524** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 357 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** SPM 927

## Key facts

- **NCT ID:** NCT00238524
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 357 (ACTUAL)
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238524, "A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00238524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*